modularmedical Archives - Medical Design Sourcing

These diabetes devices are set to launch in 2024

The Stelo glucose monitor. [Image courtesy of Dexcom]The diabetes space continues to innovate and it doesn’t look like that’s stopping any time soon, with 2024 set to be another banner year.

At the end of 2023, we compiled a list of the 10 biggest diabetes technology stories of the year. Some of those stories didn’t end in 2023, though, as a few major product launches loom on the horizon.

New CGMs, insulin pumps and combinations of the two will all be coming to the market over the next several months. Here are some of the most highly-anticipated product launches set to take place in the diabetes space in 2024 — plus some of the tech that’s already launched:

Diabetes launches on the horizon Medtronic’s new pump-sensor combo

In January, Medtronic won CE mark for its MiniMed 780G automated insulin delivery system with the Simplera Sync sensor.

The MiniMed 780G with the Simplera Sync CGM and accompanying devices. [Image courtes…

Modular Medical closes $10M public offering

The MODD1 insulin pump. [Image from Modular Medical]Modular Medical (Nasdaq:MODD) announced that it closed an underwritten public offering worth proceeds of $10 million.

The San Diego-based insulin pump maker offered just over 9 million shares of its common stock. It sold each share of common stock to the public at a price of $1.10 per share.

Manchester Explorer — managed by Modular Medical CEO Jeb Besser and board member Morgan Frank — led the financing. Other existing institutional investors also took part. Titan Partners Group, a division of American Capital Partners, acted as sole book-running manager for the offering.

Get the full story at our sister site, Drug Delivery Business News.

Modular Medical picks up new insulin pump patent for mobile device connectivity

The MODD1 insulin pump. [Image from Modular Medical]Modular Medical (Nasdaq:MODD) announced recently that it received a new U.S. patent to pair its insulin pump with a mobile device.

The company picked up U.S. Patent 11,817,197 B2 for the stream-lined pairing of a pump to a mobile device. Just last month, it submitted its 90-day MODD1 pump to the FDA for 510(k) clearance.

San Diego-based Modular Medical develops patented insulin delivery technologies, aiming to improve access to glycemic control. Its founder, Paul DiPerna, previously founded leading insulin pump maker Tandem Diabetes Care. DiPerna invented and designed Tandem’s t:slim pump. He also serves as chair and chief technology officer.

Get the full story at our sister site, Drug Delivery Business News.

Modular Medical submits next-gen insulin pump for FDA clearance

The MODD1 insulin pump. [Image from Modular Medical]Modular Medical (Nasdaq:MODD) announced today that it submitted its next-generation MODD1 insulin pump to the FDA for 510(k) clearance.

San Diego-based Modular Medical develops patented insulin delivery technologies, aiming to improve access to glycemic control. Its founder, Paul DiPerna, previously founded leading insulin pump maker Tandem Diabetes Care. DiPerna invented and designed Tandem’s t:slim pump.

The company designed the 90-day MODD1 with new microfluidics technology to allow for the low-cost pumping of insulin. Its new intuitive design makes the product simple to use and easier to prescribe.

Get the full story at our sister site, Drug Delivery Business News.

Insulin delivery tech developer Modular Medical names former Insulet CEO to board

Duane DeSisto

Modular Medical (Nasdaq:MODD) announced today that it appointed industry veteran Duane DeSisto to its board of directors.

DeSisto previously served as president, CEO and director of Insulet. He led the company as it developed the Omnipod insulin management system until his retirement in 2014.

Modular Medical, a development-stage insulin delivery technology company, aims to launch the next generation of insulin pumps. The San Diego-based company seeks to provide both ease of use and affordability in its insulin delivery offerings.

Get the full story at our sister site, Drug Delivery Business News.